We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Gooch & Housego Plc | GHH | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 586.00 | 11:36:47 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 586.00 | 586.00 | 588.00 | 586.00 |
| Industry Sector |
|---|
| ELECTRONIC & ELECTRICAL EQUIPMENT |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 03/06/2025 | Interim | GBP | 0.049 | 19/06/2025 | 20/06/2025 | 25/07/2025 |
| 03/12/2024 | Final | GBP | 0.083 | 23/01/2025 | 24/01/2025 | 28/02/2025 |
| 04/06/2024 | Interim | GBP | 0.049 | 20/06/2024 | 21/06/2024 | 26/07/2024 |
| 05/12/2023 | Final | GBP | 0.082 | 18/01/2024 | 19/01/2024 | 23/02/2024 |
| 06/06/2023 | Interim | GBP | 0.048 | 22/06/2023 | 23/06/2023 | 28/07/2023 |
| 06/12/2022 | Final | GBP | 0.079 | 19/01/2023 | 20/01/2023 | 24/02/2023 |
| 07/06/2022 | Interim | GBP | 0.047 | 23/06/2022 | 24/06/2022 | 29/07/2022 |
| 30/11/2021 | Final | GBP | 0.077 | 20/01/2022 | 21/01/2022 | 25/02/2022 |
| 01/06/2021 | Interim | GBP | 0.045 | 24/06/2021 | 25/06/2021 | 30/07/2021 |
| Top Posts |
|---|
Posted at 14/6/2025 08:52 by waldron DividendsAn interim dividend of 4.9p per share (2024: 4.9p) has been declared. This dividend will be payable to shareholders on the register as at 20 June 2025 on 25 July 2025. AYE No spending it all too quickly heres to a pleasant weekend |
Posted at 13/6/2025 12:02 by waldron interim results extractDividends An interim dividend of 4.9p per share (2024: 4.9p) has been declared. This dividend will be payable to shareholders on the register as at 20 June 2025 on 25 July 2025. The Board intends to review its dividend policy in the second half of the financial year, in order to assess whether some element of the dividend if reinvested in the business, may generate a better return for our shareholders. Prospects and outlook The strong performance achieved in the first half of the year, against a challenging macroeconomic background, is a testament to the positive progress the Group is making with the deployment of our new strategy and the resilience and depth of experience across our leadership team in navigating complex market dynamics. With our growing order book, strengthening market positions and differentiated photonics expertise aligned to structural growth drivers from megatrends, we remain confident in our ability to deliver further progress on our journey to mid-teens returns over the medium term and generate value for all our stakeholders. Following the implementation of changing global trading policies from the new US administration and the consequent retaliatory measures from China and other nations we are seeing near-term uncertainty increase, especially in our Industrial, semiconductor and Life Sciences markets. This has resulted in reduced demand levels from our industrial market persisting longer than we expected and delays with infrastructure, semiconductor and Life Sciences projects, including increased regulatory approved lead times However, we are well positioned to benefit from recovering demand levels in these markets. In our A&D business we are seeing strong demand, especially for our optical systems, advanced coatings, ring laser gyros, armour vehicle periscope and our imaging solutions for air, sea and land equipment. The overhaul and turnaround of the Group's A&D business unit supported by operational improvements, the refocusing of our R&D resources and complementary 'speed to value' acquisitions have positioned us well to meet increased demand from existing customers, capture new business opportunities and become a full optical systems solutions provider for prime defence contractors in the US, Europe and RoW. At the same time the integration of Phoenix is proceeding to plan and we are seeing significant commercial synergy opportunities arising from our combined value proposition. Global Photonics will be a strong strategic and operational fit for G&H, bringing deep application expertise, strong relationships with U.S. defence primes and complementary manufacturing capabilities to our growing Optical Systems division. This acquisition accelerates our plan to become the partner of choice for high-precision optical systems in both the UK and the U.S. and opens exciting new growth channels in North America. The establishment of a full optical systems engineering and manufacturing capability in the U.S. for the Aerospace & Defence market mirrors our successful strategy for the U.S. healthcare sector with the recent opening of our G&H Innovation Hub for Life Sciences in Rochester NY. Our order book remains at a healthy and growing level and we have over 95% cover needed to support expected FY2025 revenue. At the same time, we have entered a period of unprecedented global macroeconomic uncertainty and fluidity which has increased near-term risk. The Group is proactively managing this increased complexity and uncertainty in the global supply chain since the imposition of the new and constantly changing US tariff regime and the associated counter measures from other countries. G&H is also involved in advanced hi-tech development and production programmes some of which are dependent upon inputs from our customers, regulators and suppliers in order to progress to their expected timescales. Nevertheless, our expectations for FY2025 are unchanged and the Group has strong prospects for further profitable growth in the coming years. We expect to achieve mid-teens return on sales by 2028. |
Posted at 13/6/2025 11:14 by dudishes Tks Waldron for info. Reached 52wk high this am.US price escalation being passed onto customers - effect unknown. Dividend review 2nd half (reduction implied) imo. Recent addition to share price "Hotstocks" list, target 600. Report HS dated 20 May, price was around the 465 mark. cheers |
Posted at 03/6/2025 13:20 by martinmc123 wealthoracle.co.uk/d |
Posted at 24/5/2025 20:00 by grupo guitarlumber Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of optical components & systems, will announce its results for the six months ended 31 March 2025 on Tuesday, 3 June 2025.A meeting for analysts will be held at 10.30am BST on the morning of the results at the offices of Burson Buchanan, 107 Cheapside, London EC2V 6DN. To register attendance, please email G&H@buchanan.uk. |
Posted at 24/5/2025 18:43 by waldron DIVIDENDMAXLatest Dividends Summary Previous dividend Next dividend Status Paid Forecast Type Final Interim Per share 8.3p PENCIL IN 5p Declaration date 03 Dec 2024 (Tue) 10 Jun 2025 (Tue) Ex-div date 23 Jan 2025 (Thu) 26 Jun 2025 (Thu) Pay date 28 Feb 2025 (Fri) 25 Jul 2025 (Fri) |
Posted at 24/5/2025 18:35 by waldron 20 May 2025Gooch & Housego PLC ("G&H" or the "Company" or the "Group") Notice of Half Year Results, Analyst Meeting and IMC Presentation Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of optical components & systems, will announce its results for the six months ended 31 March 2025 on Tuesday, 3 June 2025. A meeting for analysts will be held at 10.30am BST on the morning of the results at the offices of Burson Buchanan, 107 Cheapside, London EC2V 6DN. To register attendance, please email G&H@buchanan.uk. A live audio webcast of the meeting will be available via the following link: Following the meeting, a recording of the webcast will be made available for replay at the Group's website at The Company will also be presenting via the Investor Meet Company platform on Thursday, 5 June 2025 at 4.00pm BST. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9.00am BST on Wednesday, 4 June 2025, or at any time during the live presentation. Investors and potential investors can sign up to Investor Meet Company, and add to follow Gooch & Housego PLC, via: |
Posted at 20/5/2025 20:59 by wad collector Yes just noticed that the latest acquisition is a US company. Is GHH becoming the new Judges? |
Posted at 30/4/2025 17:46 by simon gordon Perplexity:Gooch & Housego Share Valuation Analysis: Balancing Value and Risk Based on the company’s April 2025 interim trading update and financial metrics, Gooch & Housego (GHH.L) shares present a mix of value opportunities and sector-specific risks. Below is a structured analysis of its investment case: Positives Supporting Value 1. Strong Order Book and Revenue Growth Order book increased 16% to £121.5m (vs. £104.5m in Sept 2024), with £7m attributable to the Phoenix Optical acquisition. Organic order growth of 4% reflects improving customer confidence in key markets like Aerospace & Defence and Life Sciences. H1 2025 revenue rose 7.5% to £70.8m (organic constant currency), driven by subsea data cables and defence contracts. 2. Attractive Valuation Multiples P/E ratio of 29–35x (trailing), below its 10-year historical average of 34x. EV/EBITDA of 5.1–7.5x, competitive against peers in photonics and precision optics. Price-to-sales ratio of 0.71–0.84x, signaling undervaluation relative to sector averages. 3. Strategic Acquisitions and Diversification The Phoenix Optical acquisition is already generating synergies, expanding capabilities in defence optics and securing new orders. Revenue diversification: Aerospace & Defence (40% of orders), Life Sciences (30%), and Industrial (30%). 4. Dividend Resilience Forward dividend yield of 3.6%, with a payout ratio of 255%. While high, the company maintains strong liquidity (net debt reduced to £24.1m). Key Risks 1. Cyclical Exposure to Weak Industrial Markets Industrial laser and semiconductor markets remain subdued, contributing to flat organic growth in H1. ~30% of revenue tied to cyclical sectors vulnerable to macroeconomic slowdowns. 2. Tariff and Geopolitical Uncertainty Potential disruption from US tariff policies and retaliatory measures by trading partners, though the net impact is unclear. Supply chain dependencies in optics manufacturing could face cost pressures. 3. Profitability Challenges Operating margin of 5.0% (TTM) lags behind peers in advanced manufacturing. Adjusted EPS fell 24.8% YoY in FY2024 due to restructuring costs and weak industrial demand. 4. Execution Risks in Integration Successful integration of Phoenix Optical is critical; missteps could dilute margins or delay synergy realization. Conclusion: Cautious Opportunity Good Value for Risk-Tolerant Investors: Shares trade at a discount to historical averages and peers, with upside potential if industrial markets recover and Phoenix synergies materialize. Analysts project a 12-month price target of £691 (+83% upside), though this assumes flawless execution. Key Risks to Monitor: Industrial market stagnation persisting into 2025. Tariff-related cost inflation eroding margins. Recommendation: Moderate Buy for investors comfortable with cyclical sectors and multi-year horizons. Avoid for those seeking low volatility or near-term certainty. The stock’s current price (£3.77) reflects pessimism about industrial markets but underestimates G&H’s defence/life sciences growth and acquisition-led diversification. Risk-reward leans positive, but volatility is likely. |
Posted at 04/10/2024 17:22 by simon gordon EI,Thought is best to reply to you on this thread. "Simon, i had a listen to the GHH Q&A and could get little clear sense of a turnaround - perhaps that's a fault in my interpretation. What I do know is OIT are very sharp and may see a high probability of a bid." I don’t believe OIT acquired GHH for a short-term bid trade. They recognize the growth potential and the opportunity to restore margins to the mid-teens. According to OIT, GHH has historically been valued at 2.2 times EV/Sales. For 2024, it's valued at 0.9x, and for 2025, it's 0.83x. There’s always a risk of a takeover. From what I can observe, the newish CEO has recruited a talented team, which should start delivering results in 2025, with even stronger performance in 2026. Photonics is a growth industry, GHH is moving up the value chain, and the Defence division is positioned for robust growth, according to OIT. The company is currently trading at a P/E of 10x for 2025, and it’s a high-quality business. Time will tell if Charlie Peppiatt can truly get things firing. Based on the world-class executive team he’s assembling, I think there’s a good chance of success. Stuart Widdowson @ OIT - 15/8/24 “We met with the management team quite recently. They have a September year-end and are quite H2-weighted this year. There are some questions about whether they will roughly meet their targets this year. However, the management team's view for the next two or three years is radically different. They see substantial growth, not just as the destocking ends, but also due to new applications, particularly in some defense areas.” The CNC rejuvenation has taken three years to gain momentum. GHH is at the two-year mark. Year three is the point where you can judge if the CEO is delivering on his strategy. The macro backdrop looks relatively benign for 25. New CEO at CNC; -6/21: 92.5p -6/22: 75p -6/23: 65p -6/24: 102p New CEO at GHH: -9/22: 575p -9/23: 508p -9/24: 450p I’m hoping CNC really gains momentum in 2025 through 2028 as the investment in growth starts to pay off. GHH is also investing for growth, and it should deliver results in the coming years. The more I examine Charlie Peppiatt’s strategy, the more I believe he possesses some of the qualities of an "Intelligent Fanatic." The most important factors are recruiting highly talented executives, incentivizing them effectively, and having a clear overarching message for employees. Charlie is successfully implementing all three. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
